Registry of patients with low grade gliomas
Registry Study on Epidemiological and Biological Disease Profile as Well as Clinical Outcome in Patients With Low Grade Gliomas: The LOG-Glio-Project
This study is collecting information from patients with low grade gliomas to see how the disease behaves and what factors might affect treatment and outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Ulm Academic / other |
| Locations | 1 site (Ulm) |
| Trial ID | NCT02686229 on ClinicalTrials.gov |
What this trial studies
The LoG-Glio-Registry collects comprehensive data on patients diagnosed with low grade gliomas from a network of German hospitals. This observational study focuses on gathering radiological, clinical, epidemiological, and molecular information to better understand the disease profile and clinical outcomes. By analyzing this data, researchers aim to identify patterns and factors that influence the progression and treatment of low grade gliomas.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older with a radiologically suspected diagnosis of low grade glioma.
Not a fit: Patients with severe neurological or psychiatric disorders that prevent informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this registry could enhance understanding of low grade gliomas, leading to improved patient management and treatment strategies.
How similar studies have performed: Other studies utilizing registry approaches for gliomas have shown promise in understanding disease characteristics and outcomes, indicating that this methodology is supported by previous successes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with radiological suspected diagnosis of a low grade glioma * Age ≥ 18 years. There is no upper age limit. Exclusion Criteria: * Severe neurological or psychiatric disorder interfering with ability to give an informed consent * No consent for registration, storage and processing of the individual disease characteristics and course as well as information of the family physician about study participation * No consent for bio-banking of patient's biological specimens and performance of analyses on stored material.
Where this trial is running
Ulm
- University of Ulm — Ulm, Germany (Recruiting)
Study contacts
- Study coordinator: Jan Coburge, MD
- Email: jan.coburger@uni-ulm.de
- Phone: 082219628858
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.